Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions-Reference-Cited by-同舟云学术

Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions

Published:2013-04-25 Issue:7 Volume:41 Page:1367-1374
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Ellens Harma,Deng Shibing,Coleman JoAnn,Bentz Joe,Taub Mitchell E.,Ragueneau-Majlessi Isabelle,Chung Sophie P.,Herédi-Szabó Krisztina,Neuhoff Sibylle,Palm Johan,Balimane Praveen,Zhang Lei,Jamei Masoud,Hanna Imad,O’Connor Michael,Bednarczyk Dallas,Forsgard Malin,Chu Xiaoyan,Funk Christoph,Guo Ailan,Hillgren Kathleen M.,Li LiBin,Pak Anne Y.,Perloff Elke S.,Rajaraman Ganesh,Salphati Laurent,Taur Jan-Shiang,Weitz Dietmar,Wortelboer Heleen M.,Xia Cindy Q.,Xiao Guangqing,Yamagata Tetsuo,Lee Caroline A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference45 articles.

1. Kinetic Identification of Membrane Transporters That Assist P-glycoprotein-Mediated Transport of Digoxin and Loperamide through a Confluent Monolayer of MDCKII-hMDR1 Cells

2. Agarwal S Arya V Zhang L (2012) Review of P-gp inhibition data in recently approved new drug applications: utility of the proposed [I1]/IC50 and [I2]/IC50 criteria in the P-gp decision tree. J Clin Pharmacol, in press.

3. P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels

4. Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?

5. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs;Belz;Clin Pharmacol Ther,1983

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10

2. Comparison and summary of in silico prediction tools for CYP450-mediated drug metabolism;Drug Discovery Today;2023-10

3. Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk;Journal of Pharmaceutical Sciences;2023-06

4. Clinical Pharmacokinetics of Approved RNA Therapeutics;International Journal of Molecular Sciences;2023-01-01

5. Clinical Relevance of Hepatic and Renal P‐gp/ BCRP Inhibition of Drugs: An International Transporter Consortium Perspective;Clinical Pharmacology & Therapeutics;2022-06-22